Company page

Medivir Ab

Medivir Ab is a public company listed on the Swedish market under the ticker MVIR, with a market capitalization of approximately 90.9 million USD. The company focuses on developing innovative treatments in the field of infectious diseases and oncology. Medivir aims to advance its pipeline of drug candidates to address unmet medical needs.

profileMVIR:OMXSTOAI content: aiUpdated June 24, 2026/company/medivir-ab/c-on5kuspj
Medivir Ab logo
Ticker
MVIR:OMXSTO
Asset type
Stock
Market cap
$90.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK